Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39' Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding Protein (FBP) Expressing Tumors
Journal of the American College of Surgeons - Netherlands
doi 10.1016/j.jamcollsurg.2017.07.030
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2017
Authors
Publisher
Elsevier BV